Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1220874 | Journal of Pharmaceutical and Biomedical Analysis | 2014 | 27 Pages |
•Practical issues in application of multi-step strategy for the characterization of IMPs/DPs.•Practical aspects of sample preparation, method development and instrument settings.•Critical practical considerations in acquisition and interpretation of mass results.•Establishing fragmentation pathways of drug and IMPs/DPs from mass results and their comparison.•Confirmation of structures through mechanistic explanation.
Liquid chromatography–mass spectrometry (LC–MS) is considered today as a mainstay tool for the structure characterization of minor components like impurities (IMPs) and degradation products (DPs) in drug substances and products. A multi-step systematic strategy for the purpose involves high resolution mass and multi-stage mass studies on both the drug and IMPs/DPs, followed by comparison of their fragmentation profiles. Its successful application requires consideration of many practical aspects at each step. The same are critically discussed in this review.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide